A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors

ABSTRACT: This is a phase I clinical study to evaluate the safety and tolerability of CAR-T in patients with CEA-positive advanced malignant solid tumors, and to obtain the maximum tolerated dose of CAR-T and phase II Recommended dose.

DISEASE(S): Stomach Cancer,Neoplasm Metastasis,Colorectal Cancer,Esophageal Cancer,Pancreatic Cancer,Stomach Neoplasms,Metastatic Tumor,Recurrent Cancer

PROVIDER: 2732525 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR